Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Allergopharma

Status and phase: Completed; Phase 3

Conditions: Allergy

Treatments: Biological: wasp venom

Study type: Interventional

Funder types: Industry

Identifiers

NCT00263926

Al1000ig

Details and patient eligibility

About

The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• History of wasp venom allergy,
• Positive RAST to wasp venom,
• Positive skin prick test to wasp venom

Exclusion criteria

• Serious chronic diseases

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)